APE1i	APE1 inhibitors
ATMi	ATM inhibitors
ATRi	ATR inhibitors
BER	base excision repair
CHEK1i	CHEK1 inhibitors
DDR	DNA damage response
DSB	double-strand break
EMA	European Medicine Agency
EOC	epithelial ovarian carcinoma
FDA	Food and Drug Administration U.S. agency
GWAS	genome wide association study
HGSOC	high-grade serous ovarian carcinoma
HR	homologous recombination repair
MMR	mismatch repair
MSI	microsatellite instability
NER	nucleotide excision repair
NHEJ	non-homologous end joining
OvC	ovarian cancer
OS	overall survival
PARPi	poly(ADP-ribose) polymerase inhibitors
PFS	progression-free survival
SNP	single-nucleotide polymorphism
SSB	single-strand break
WEE1i	WEE1 inhibitors
wt	wild-type